2025 · 4th Quarter (Oct 1 - Dec 31)

EVONIK CORPORATION

Filed by EVONIK CORPORATION.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: $60,000.00
Expenses: Not reported
Registrant: EVONIK CORPORATION
Client: EVONIK CORPORATION
Filing UUID: 74d9f55b-582b-4867-849e-f9115a9c9cc1
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

TAR · Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

CHM · Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

ENV · Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Literal federal measure citations: S.623, H.R.1415

BUD · Budget/Appropriations

FY26 appropriations actions H.R. 5371/ P.L. 119-37 FY2026 Continuing Appropriations, Agriculture, Leg. Branch & Extensions Act

Literal federal measure citations: H.R. 5371

TAX · Taxation/Internal Revenue Code

General issues related to corporate tax

TRD · Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

RRR · Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.